{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2022"],"data_sharing_plan":["IPD Sharing (as of September 2023): No"],"condition":["Carcinoid Intestine Tumor","Carcinoid Tumor","Carcinoid Syndrome Diarrhea","Diarrhea","Carcinoid Tumor of Cecum","0 SINDROME CARCINOIDE","Carcinoid Syndrome","Neoplasms","Carcinoid Tumor of Pancreas","Malignant Carcinoid Syndrome","Carcinoid Tumor of Ileum","Carcinoid","Pancreatic Neoplasms","Carcinoid Tumor of Liver","Serotonin Syndrome"],"disease":["Carcinoid Intestine Tumor","Carcinoid Tumor","Carcinoid Syndrome Diarrhea","Carcinoid Tumor Of Pancreas","Carcinoid Tumor Of Liver","Diarrhea","Carcinoid Syndrome","Neoplasms","0 Sindrome Carcinoide","Malignant Carcinoid Syndrome","Carcinoid Tumor Of Cecum","Carcinoid Tumor Of Ileum","Carcinoid","Pancreatic Neoplasms","Serotonin Syndrome"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2726811"],"location":["Argentina","Hungary","Czechia","United States","United Kingdom","Spain","Russia","Canada","Austria","Belgium","Brazil","Poland","Italy","Mexico","Israel","France","Bulgaria","Serbia","Peru","Germany"],"study_start_month":["6"],"keyword":["CRN00808","Somatostatin agonist","Lanreotide","Octreotide","Neuroendocrine tumor","Paltusotine"],"repository":["ECRIN MDR"],"study_status":["Recruiting"],"additional_accession":[]},"is_claimable":false,"name":"Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome","description":"The purpose of this study is to evaluate the safety, pharmacokinetics (PK), and exploratory dose response of paltusotine treatment in subjects with carcinoid syndrome. This study consists of a Randomized Treatment Phase followed by an Open-Label Extension (OLE) Phase.","dates":{"creation":"2022-06-15"},"accession":"2726811","cross_references":{"ClinicalTrials___gov":["NCT05361668"],"EU Clinical Trials Register":["2022-000762-18"],"Registro Peruano de Ensayos Clínicos":["PER-049-22"]}}